June 8, 2018
Snapshot Top 10: Dow Jones U.S. Pharmaceuticals Index



The Top 10 performing stocks in the Dow Jones U.S. Pharmaceuticals Index are shown for seven different investment strategies. Whether you are looking for value, growth or dividend stocks, or you want stocks that rank well overall, you can see the top 10 stock picks, together with how they rank on a scale of 1 to 100 from the perspective of different investment strategies. We have also added our newest Sentiment and 360° View ranks, which encapsulate the market voices of analysts and professional investors into a simple ranking for easily evaluating stocks. As an objective research provider, Obermatt has been refining its stock analysis algorithms for more than 10 years (no AI used here!)

Select any stock for the detailed analysis of that stock's performance across the different investment analyses. Please note that the Top 10 stocks focus only on Large to XX-Large companies.


What the six ranks mean

For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. The higher the rank, the better the stock performs than its peers. And, we do this for six investment strategies:

Value - shows how good of a value the stock is. Green is "inexpensive"; red is "expensive".

Growth - shows a company's growth potential. Green is "high growth" expected; red is "tough times ahead".

Safety - relates to the amount of debt a company has. Green is low debt level; red is high debt level.

Combined Financial - this isn't an average of the first three ranks but rather a consolidated view across several financial indicators. Green = good; red = tread carefully.

(NEW) Sentiment - quantifies professional analyst ratings and holdings as well as market pulse. Green = positive sentiment; red = skepticism (Only available to Premium Subscribers).

(NEW) 360° View - the ultimate rating with all financial and non-financial indicators.

Special Analysis: TOP 10 Dividend Investment Strategy

Many people ask for tips about dividend stocks. These are the Top 10 dividend stocks in the Dow Jones U.S. Pharmaceuticals Index as of June 8, 2018.

No top 10 list was published for this market, date and strategy.

TOP 10 Dividend Investment Strategy Value Strategy DIVIDEND Value Strategy VALUE Combined Strategy COMBINED 360° Strategy 360° VIEW

☀ This company has a special achievement which is documented on its stock research page.

June 8, 2018. Top 10s are published weekly following the . ( or for more stocks)


D.J. US Pharmaceutical Top 10: Obermatt 360° Investment Strategy

No top 10 list was published for this market, date and strategy.

TOP 10 Obermatt 360° Investment Strategy 360° Strategy 360° VIEW Value Strategy VALUE Combined Strategy COMBINED Sentiment Strategy SENTIMENT

June 8, 2018. Top 10s are published weekly following the . ( or for more stocks)


D.J. US Pharmaceutical Top 10: Sentiment Investment Strategy

No top 10 list was published for this market, date and strategy.

TOP 10 Sentiment Investment Strategy Sentiment Strategy SENTIMENT Value Strategy VALUE Combined Strategy COMBINED 360° Strategy 360° VIEW

June 8, 2018. Top 10s are published weekly following the . ( or for more stocks)


D.J. US Pharmaceutical Top 10: Value Investment Strategy

TOP 10 Value Investment Strategy Value Strategy VALUE Growth Strategy GROWTH Combined Strategy COMBINED 360° Strategy 360° VIEW
1. Prestige (L, US)   Pharmaceuticals
1. Prestige (L, US)   Pharmaceuticals n/a n/a n/a n/a
2. Pfizer (XXL, US)   Pharmaceuticals
2. Pfizer (XXL, US)   Pharmaceuticals n/a n/a n/a n/a
3. Phibro Animal (L, US)   Pharmaceuticals
3. Phibro Animal (L, US)   Pharmaceuticals n/a n/a n/a n/a
4. Lannett (M, US)   Pharmaceuticals
4. Lannett (M, US)   Pharmaceuticals n/a n/a n/a n/a
5. Catalent (XL, US)   Pharmaceuticals
5. Catalent (XL, US)   Pharmaceuticals n/a n/a n/a n/a

June 8, 2018. Top 10s are published weekly following the . ( or for more stocks)


D.J. US Pharmaceutical Top 10: Growth Investment Strategy

TOP 10 Growth Investment Strategy Growth Strategy GROWTH Value Strategy VALUE Combined Strategy COMBINED 360° Strategy 360° VIEW
1. Supernus Pharma (M, US)   Pharmaceuticals
1. Supernus Pharma (M, US)   Pharmaceuticals n/a n/a n/a n/a
2. Nektar (XS, US)   Pharmaceuticals
2. Nektar (XS, US)   Pharmaceuticals n/a n/a n/a n/a
3. AbbVie (XXL, US)   Biotechnology
3. AbbVie (XXL, US)   Biotechnology n/a n/a n/a n/a
4. Catalent (XL, US)   Pharmaceuticals
4. Catalent (XL, US)   Pharmaceuticals n/a n/a n/a n/a
5. Eli Lilly (XXL, US)   Pharmaceuticals
5. Eli Lilly (XXL, US)   Pharmaceuticals n/a n/a n/a n/a
6. Zoetis (XL, US)   Pharmaceuticals
6. Zoetis (XL, US)   Pharmaceuticals n/a n/a n/a n/a
7. Prestige (L, US)   Pharmaceuticals
7. Prestige (L, US)   Pharmaceuticals n/a n/a n/a n/a

June 8, 2018. Top 10s are published weekly following the . ( or for more stocks)


D.J. US Pharmaceutical Top 10: Safety Investment Strategy

TOP 10 Safety Investment Strategy Safety Strategy SAFETY Value Strategy VALUE Combined Strategy COMBINED 360° Strategy 360° VIEW
1. Supernus Pharma (M, US)  Pharmaceuticals
1. Supernus Pharma (M, US)   Pharmaceuticals n/a n/a n/a n/a
2. Pacira BioSciences (M, US)  Pharmaceuticals
2. Pacira BioSciences (M, US)   Pharmaceuticals n/a n/a n/a n/a
3. Bristol-Myers Squibb (XXL, US)  Pharmaceuticals
3. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals n/a n/a n/a n/a
4. Catalent (XL, US)  Pharmaceuticals
4. Catalent (XL, US)   Pharmaceuticals n/a n/a n/a n/a
5. Johnson & Johnson (XXL, US)  Pharmaceuticals
5. Johnson & Johnson (XXL, US)   Pharmaceuticals n/a n/a n/a n/a

June 8, 2018. Top 10s are published weekly following the . ( or for more stocks)


D.J. US Pharmaceutical Top 10: Combined Investment Strategy

TOP 10 Combined Investment Strategy Combined Strategy COMBINED Value Strategy VALUE Growth Strategy GROWTH 360° Strategy 360° VIEW
1. Supernus Pharma (M, US)  Pharmaceuticals
1. Supernus Pharma (M, US)   Pharmaceuticals n/a n/a n/a n/a
2. Catalent (XL, US)  Pharmaceuticals
2. Catalent (XL, US)   Pharmaceuticals n/a n/a n/a n/a
3. Prestige (L, US)  Pharmaceuticals
3. Prestige (L, US)   Pharmaceuticals n/a n/a n/a n/a
4. Lannett (M, US)  Pharmaceuticals
4. Lannett (M, US)   Pharmaceuticals n/a n/a n/a n/a
5. Pacira BioSciences (M, US)  Pharmaceuticals
5. Pacira BioSciences (M, US)   Pharmaceuticals n/a n/a n/a n/a

June 8, 2018. Top 10s are published weekly following the . ( or for more stocks)


☀ This company has a special achievement which is documented on its stock research page.

Top 10 lists may contain fewer than 10 stocks due to Obermatt’s top 10 quality standards.

Top 10 Stocks from the purely fact-based Obermatt Method in the stock index Dow Jones U.S. Pharmaceuticals Index from June 8, 2018.

Today's Top 10
More Top Stocks
Your Watchlist

Top 10 Stock History D.J. US Pharmaceutical



Obermatt Portfolio Performance
We’re so convinced about our research, that we buy our stock tips.
See the performance of the Obermatt portfolio.